Apollo People

Dr Hitesh Sanganee

Head of Transactions, Oncology Business Development and Licensing
Chairman of the LLP-committee

Dr Hitesh Sanganee

Hitesh is currently a Head of the Emerging Innovations group in AstraZeneca. The group is involved in three main areas. Execution of the open innovation strategy, externalisation and internalisation of repurposed assets. Promotion of Entrepreneurial activity within and outside of AZ and bringing emerging innovations into AZ.

Previously his role was in the science function within the AstraZeneca. His main role was as a chemistry cluster lead inputting into external and internal drug repositioning projects and potential in-licensing projects. Other roles also have included CDL (candidate drug leader) working on regenerative medicine, and a Team Leader in the respiratory & inflammation therapeutic area.

He originally received his BA and DPhil from Oxford University in chemistry and subsequently held a postdoctoral research position at Florida State University. He joined AstraZeneca as a Medicinal Chemist in 1999 conducting research within respiratory & inflammation related disease areas and has led teams to successful milestone transitions in all phases of drug discovery. He recently obtained an MBA from Cambridge University.